Aricept-induced nightmares in Alzheimer's disease: 2 case reports

Journal of the American Geriatrics Society

Volumn 46, Issue 1, 1998, Pages 119-120

  Ross, Joel S ^a   Shua Haim, Joshua R ^a  

^a Meridian Health Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

AGED; ALZHEIMER DISEASE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DREAM; FEMALE; HUMAN; LETTER; MALE; SLEEP DISORDER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DREAMS; FEMALE; HUMANS; INDANS; MALE; PIPERIDINES; SLEEP DISORDERS;

EID: 0031603030     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01033.x     Document Type: Letter

References (3)

1. Aricept (donepezil HCL) package insert. New York: Pfizer, 1996.
2. Rogers SL, Friedhoff LT,. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7: 293-303.
3. Yamanishi Y., Ogura H., Kosasa T., et al., Inhibitory action of donepezil, a novel acetylcholinesterase inhibitor, on cholinesterase. Comparison with other inhibitors. In:, Nagatsu T., Fisher A., Yoshida M., eds. Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Vol. 2. New York: Plenum Press, 1990, pp. 409-413.